No Data
CONSUN PHARMA: ANNUAL REPORT 2024
Consun Pharmaceutical Unit Gets China Nod for Renal Disease Drug Trial
CONSUN PHARMA: NOTICE OF ANNUAL GENERAL MEETING
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
CONSUN PHARMA (01681) received the "Drug Clinical Trial Approval Notification" for SK-09 tablets.
CONSUN PHARMA (01681) announced that the company has received the relevant SK-09 tablet issued by the National Medical Products Administration of China...
Express News | Consun Pharmaceutical - Received "Notice of Approval for Clinical Trial of Drug Issued by in Relation to SK-09 Tablet Nmpa
